HIDA President and CEO Matthew J. Rowan authored an opinion piece illustrating the unprecedented challenges COVID-19 created for the healthcare supply chain, including product shortages and the emergence of opportunistic brokers within the marketplace. To better prepare for a potential virus resurgence and avoid future product shortages, he recommends that government agencies partner with commercial distributors to manage a national reserve of key products and increase diversity and elasticity throughout the supply chain.